Company Information
USD
13.08
- (-0.7%)
NASDAQ:NEO, NEOGENOMICS, INC.
Industry: Diagnostics & Research
End of Day: 25 June 2024 GMT-4
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
Address
9490 NeoGenomics Way
Website
Classification
Sector
Healthcare
Industry Group
Medical Diagnostics & Research
Industry
Diagnostics & Research
Key Executives
Ms. Alicia C. Olivo
Executive VP, Divisional/General Counsel/Secretary
Mr. Bruce K. Crowther
Director
Mr. Jeffrey S. Sherman
CFO
Ms. Lynn A. Tetrault
Chairman of the Board/Director
Mr. Anthony P. Zook
Director
Mr. Michael A. Kelly
Director
Mr. Christopher M. Smith
CEO/Director
Dr. Alison L. Hannah, M.D.
Director
Mr. Gregory D. Aunan
Chief Accounting Officer/Senior VP
Mr. Stephen M. Kanovsky
Director
Mr. David B. Perez
Director
Ms. Elizabeth A. Floegel
Director
Dr. Neil Gunn
Director
Ms. Cynthia J. Dieter
Chief Accounting Officer/Controller
Ms. Melody Harris
President, Divisional
Mr. Vishal Sikri
President, Divisional
Mr. Shashikant Kulkarni
Chief Scientific Officer/Executive VP, Divisional
Mr. Warren Stone
President, Divisional
Ownership
Institution Holdings
BlackRock Inc
19,980,993 (15.658%)
BlackRock Fund Advisors
14,705,866 (11.524%)
Vanguard Group Inc
14,169,665 (11.104%)
Brown Advisory Holdings Inc
9,643,599 (7.557%)
T. Rowe Price Investment Management,Inc.
6,382,515 (5.002%)
HHG PLC
6,348,613 (4.975%)
State Street Corporation
4,844,945 (3.797%)
Janus Henderson Investors US LLC
4,677,015 (3.665%)
Goldman Sachs Group Inc
4,574,290 (3.585%)
T. Rowe Price
4,406,967 (3.453%)
Individual Holdings
Mr. Vishal Sikri
128,921 (0.101%)
Mr. Jeffrey S. Sherman
125,662 (0.099%)
Dr. Alison L. Hannah, M.D.
107,433 (0.084%)
Ms. Melody Harris
102,955 (0.081%)
Mr. Warren Stone
83,775 (0.066%)
Mr. Shashikant Kulkarni
82,673 (0.065%)
Mr. Bruce K. Crowther
65,120 (0.051%)
Ms. Lynn A. Tetrault
50,062 (0.039%)
Mr. Clive Morris
41,280 (0.034%)
Ms. Alicia C. Olivo
34,866 (0.027%)
Funds Holdings
iShares Core S&P Small-Cap ETF
8,682,389 (6.804%)
Vanguard US Total Market Shares ETF
4,092,757 (3.207%)
Vanguard Total Stock Market Index Fund
4,092,757 (3.207%)
Vanguard Small Cap Index
3,255,116 (2.551%)
iShares Russell 2000 ETF
3,092,973 (2.424%)
T. Rowe Price Small-Cap Stock Fund
2,930,800 (2.297%)
T. Rowe Price US Small-Cap Core Equity
2,930,800 (2.297%)
Delaware Small Cap Core Fund
2,439,153 (1.911%)
Vanguard Institutional Extnd Mkt Idx Tr
1,883,000 (1.476%)
Vanguard Small Cap Growth Index Fund
1,813,424 (1.421%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
